In June 2021, the Federal Drug Administration did something it hadn’t in nearly a decade.
It approved the first new medication designed specifically for chronic weight management since Saxenda (liraglutide), a daily injectable, in 2014. The new medication was called Wegovy (semaglutide), and it has since made quite an impact on patients who struggle to lose harmful weight. MORE …
Tags: medications, pharmaceuticals, semaglutide, wegovy, weight loss drugs
